SCHOTT Pharma (Germany) Probability of Future Stock Price Finishing Under 27.20

1SXP Stock   27.60  0.42  1.55%   
SCHOTT Pharma's future price is the expected price of SCHOTT Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of SCHOTT Pharma AG performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  
Please specify SCHOTT Pharma's target price for which you would like SCHOTT Pharma odds to be computed.

SCHOTT Pharma Target Price Odds to finish below 27.20

The tendency of SCHOTT Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to  27.20  or more in 90 days
 27.60 90 days 27.20 
about 8.14
Based on a normal probability distribution, the odds of SCHOTT Pharma to drop to  27.20  or more in 90 days from now is about 8.14 (This SCHOTT Pharma AG probability density function shows the probability of SCHOTT Stock to fall within a particular range of prices over 90 days) . Probability of SCHOTT Pharma AG price to stay between  27.20  and its current price of 27.6 at the end of the 90-day period is under 4.
Assuming the 90 days trading horizon SCHOTT Pharma AG has a beta of -0.38. This suggests as returns on the benchmark increase, returns on holding SCHOTT Pharma are expected to decrease at a much lower rate. During a bear market, however, SCHOTT Pharma AG is likely to outperform the market. Additionally SCHOTT Pharma AG has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   SCHOTT Pharma Price Density   
       Price  

Predictive Modules for SCHOTT Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as SCHOTT Pharma AG. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

SCHOTT Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. SCHOTT Pharma is not an exception. The market had few large corrections towards the SCHOTT Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold SCHOTT Pharma AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of SCHOTT Pharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.35
β
Beta against Dow Jones-0.38
σ
Overall volatility
2.25
Ir
Information ratio -0.3

SCHOTT Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of SCHOTT Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for SCHOTT Pharma AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
SCHOTT Pharma AG generated a negative expected return over the last 90 days

SCHOTT Pharma Technical Analysis

SCHOTT Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. SCHOTT Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of SCHOTT Pharma AG. In general, you should focus on analyzing SCHOTT Stock price patterns and their correlations with different microeconomic environments and drivers.

SCHOTT Pharma Predictive Forecast Models

SCHOTT Pharma's time-series forecasting models is one of many SCHOTT Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary SCHOTT Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about SCHOTT Pharma AG

Checking the ongoing alerts about SCHOTT Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for SCHOTT Pharma AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
SCHOTT Pharma AG generated a negative expected return over the last 90 days